Finnrick - Ensuring a Safer and More Transparent Supply Chain
Tianjin Eleli Technology Development

Tianjin Eleli Technology Development

Retatrutide

Finnrick tested 8 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Tianjin Eleli Technology Development between 26 Jan 2026 and 8 May 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
E
BAD
Tianjin Eleli Technology Development
Retatrutide
Tested 8 Samples
Last test 8 May 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Test My Sample

Other Retatrutide tests from top-rated vendors:

Paradigm Peptide
A
Peptide Partners
A
Lipeptides
A

All Retatrutide tests from Tianjin Eleli Technology Development

Samples are tested in commercial labs

Tests Count

8

Scores

AVG6.9MIN2.0MAX10.0

Last

8 May 2026

First

26 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
8 May 2026View10.030mg28.7mg-4.3%99.90%843096Silver Label / Silver Crimp / White CapLab EPublic
28 Apr 2026View7.830mg28.3mg-5.7%99.90%(no batch ID)Silver Label / Silver Crimp / White CapLab EPublic
25 Mar 2026View8.020mg20.6mg+3.0%99.90%(no batch ID)No Label / Gold Crimp / Black CapLab GPublic
3 Mar 2026View2.030mg
⚠️ Sample does not contain Retatrutide
12/2025No Label / Silver Crimp / Blue CapLab EPublic
3 Mar 2026View7.410mg10.2mg+2.0%99.67%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic
10 Feb 2026View6.420mg21.9mg+9.5%99.80%(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic
4 Feb 2026View6.110mg9mg-10.0%98.60%10No Label / Silver Crimp / Orange CapLab GPublic
26 Jan 2026View7.815mg15.2mg+1.3%99.80%(no batch ID)White Label / Silver Crimp / Orange CapLab EPublic
Test My Sample
Test my peptides for free